Sign InZOM's Mixed Indicators and Increased Share Price Earn it a Hold Rating
Summary
Zomedica Corp. (ZOM) experienced a 5.06% increase in share price on October 06, 2023, and while analysts recommend buying the stock, mixed technical indicators and declining moving averages suggest uncertainty, leading to a final Hold rating.
Fundamental Analysis
Zomedica Corp. (ZOM) is listed on the AMEX exchange with a total market capitalization of $168.85 million. Across the 979.95 million shares outstanding, the share price last closed at $0.17 on October 06, 2023. This represents an increase of $0.01 or 5.06% in the day's trading session.
The corporation has seen a noticeable fluctuation in share prices in the past year, with a year high of $0.34 and year low of $0.15. The last recorded EPS (Earnings Per Share) stood at -0.02 and a PE (Price to Earnings) ratio of -8.61.
On the financial calendar, ZOM is scheduled to announce its next earnings on November 13, 2023. Consensus from the analysts stands at "Buy", with 2 recommending "buy" and none advocating for "hold", "sell", or "strong sell".
Technical Analysis
Over the last 50 days, ZOM's shares maintained an average rate of $0.19, while the 200-day moving average showed a higher value of $0.21. These figures might suggest a downward trend over the longer-term. The MACD (Moving Average Convergence Divergence) for the past 3 months stands at -0.007252, indicating bearish momentum.
The RSI (Relative Strength Index) for a 14-day period is at 49, suggesting the stock is neither in overbought nor oversold territory. As for the stock's volatility, the ATR (Average True Range) stands at 4.21 and has a stop-loss point at $0.16. The support and resistance lines for the share are situated at $0.17 and $0.19, respectively.
The trading volume for the latest session was about 3.44 million, less than the average trading volume of about 3.99 million shares.
Forecasts and Rating
Looking to the future, predictions for the next trading day (October 09, 2023) and the upcoming week are hardly straightforward due to the mixed technical indicators. The RSI suggests a balanced condition, while the MACD indicates possible downward pressure.
Nevertheless, if the current momentum and investor sentiment can maintain the upward movement, the stock could potentially approach the resistance line at $0.19 in the next trading day and throughout the coming week.
However, cautious investors should also consider the current support line, MACD indicator, and the stop-loss marker in case the stock's trajectory changes.
Given ZOM's below-average EPS, negative PE ratio, and overall declining moving averages, but with an analysts' consensus of "Buy" and the recent 5.06% increase in the share price, the final rating on ZOM is a "Hold". This is due to the mixed indicators suggesting uncertainty, making it suitable primarily for investors tolerant to higher risk.
